Congenital hypothyroidism: a review of the risk factors

Setila Dalili1, Seyed Mahmood Rezvany, Arsalan Dadashi

  • 1Guilan Health Center, Guilan University of Medical Sciences, Guilan, Iran. setiladalili1346@yahoo.com

Acta Medica Iranica
|January 8, 2013
PubMed

Insights

Congenital hypothyroidism (CH) affects 1 in 542 newborns in Guilan, with low birth weight and postdate delivery identified as key risk factors. Screening programs are crucial for early detection and management of this condition.

Area of Science:

  • Endocrinology
  • Neonatal Health
  • Public Health

Background:

  • Congenital hypothyroidism (CH) is a significant cause of preventable intellectual disability.
  • Neonatal screening programs are essential for early detection and intervention.
  • Understanding risk factors associated with CH is crucial for targeted prevention strategies.

Purpose of the Study:

  • To evaluate the prevalence and situation of CH in Guilan province through a neonatal screening program.
  • To determine the correlation between CH and various perinatal factors including birth weight, gestational age, and seasonality.
  • To identify potential risk factors for CH in the screened population.

Main Methods:

  • A 5-year neonatal screening program (2006-2010) for CH in Guilan province.
  • Serum TSH levels measured in neonates 3-5 days after birth; elevated levels prompted further endocrinological evaluation.
  • Analysis of public health data including birth weight, gestational age, birth season, and delivery route for screened neonates.

Main Results:

  • A total of 119,701 neonates were screened, with a confirmed CH prevalence of 1:542 (10.8% of referred cases).
  • Low birth weight (LBW), postdate delivery, and macrosomia were significantly more prevalent in neonates with CH.
  • Normal vaginal delivery (NVD) was also more frequent in CH cases, while no association was found with gender or birth season.

Conclusions:

  • Low birth weight, postdate delivery, and macrosomia are identified as significant risk factors for congenital hypothyroidism.
  • Neonatal screening programs effectively identify CH, highlighting the importance of monitoring these risk factors.
  • The study found no correlation between CH and birth season or delivery method (Caesarean section).

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...